Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia—precursor of endometrial cancer

This publication has 36 references indexed in Scilit:

• TNFα Expression in Hyperplastic Endometrium
  American Journal of Reproductive Immunology, 2000
• Down-Regulation of Bcl-2 Is a Potential Marker of the Efficacy of Progestin Therapy in the Treatment of Endometrial Hyperplasia
  Gynecologic Oncology, 1999
• Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome c
  Journal of Biological Chemistry, 1998
• Serum Deprivation-Induced Apoptosis in Cultured Porcine Granulosa Cells Is Characterized by Increased Expression of p53 Protein, Fas Antigen and Fas Ligand and by Decreased Expression of PCNA.
  Endocrine Journal, 1998
• Fas‐induced apoptosis, and diseases caused by its abnormality
  Genes to Cells, 1996
• FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
  Cell, 1996
• Persistent expression of bcl-2 onco-protein in endometrial carcinoma correlates with hormone receptor positivity
  International Journal of Gynecologic Cancer, 1996
• Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
  Cell, 1993
• Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy
  International Journal of Cancer, 1979
• Progestin therapy in endometrial hyperplasia
  Gynecologic Oncology, 1974